© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the late 1960s, organic chemists searching for functional building blocks started experimenting with unique alkyl imines. Researchers first isolated what would become known as 7-Pime while working with specialized piperidine derivatives. They found that subtle tweaks to synthesis could give them a compound tough enough for industrial needs but reactive enough for creative chemistry. Through years of incremental trial, 7-Pime gained a reputation in the pharmaceutical and fine chemical sectors. It began as a niche curiosity, hardly available outside of specialized labs, slowly earning its place as procedures matured. The steady progress in reaction yields, purification, and overall safety mirrored the maturing industry focus on reliable specialty chemicals for scalable processes.
7-Pime typically shows up as a crystalline solid or thick oil, depending on moisture and storage atmosphere. Its reputation as a versatile intermediate stems from its core structure—a seven-membered saturated ring carrying a methyl imine substituent. Those in manufacturing value it for clean reactions and the way it can step into more complex syntheses. It's not a shelf dweller; its reactivity means suppliers often ship in limited quantities under controlled packaging. Buyers look to 7-Pime for a stepping stone into drug frameworks and specialty polymers that don't want aromatic rings cluttering up the molecular layout.
The standout feature of 7-Pime is that seven-membered backbone. Unlike the five- or six-membered cousins, it combines ring flexibility with stability that resists unexpected decompositions. At room temperature, you might spot faint yellowing if the batch ran hot, but pure samples remain almost colorless. The melting point hovers in the upper double digits Celsius; exact values depend on trace nitrogen content. In solvents, 7-Pime dissolves best in polar aprotic types and needs careful handling in water—hydrolysis can be too eager. The compound smells faintly amine—sharp, a little pungent, certainly no candidate for food chemistry. Chemically, it walks a tightrope: stable under gentle conditions, eager to trade partners with acids, oxidants, and nucleophiles when provoked.
Chem suppliers list 7-Pime with a minimum purity of 98%, typically verified by NMR and GC-MS. Water content must stay below 1% to avoid product loss. Labels flag flammability and the risk from long-term inhalation. UN identification highlights moderate toxicity, and hazard diamonds call out possible impacts on skin and mucous membranes. Packaging standards require leak-proof dark bottles, with temperature and humidity protections spelled out. Most suppliers recommend refrigerated storage between 4 and 8°C in tightly closed containers, keeping out both bright light and oxygen. It travels under minor hazardous chemical codes, so shippers demand full regulatory compliance.
Lab-scale 7-Pime often comes from cyclization of hexanedial precursors in the presence of mixed alkali catalysts. Teams typically add a methylamine source to the crude cyclized product, driving off water under vacuum. Industrial producers shift to continuous reactors, using flow chemistry to keep temperatures stable and limit runaway side reactions. Solvent choices lean toward dry, acid-free ether systems, as trace acids spark off unwanted ring opening. A final column purification strips away side products—laboratory workers often complain about the effort, but the process rewards attention to detail. Yields can hit 75 to 80 percent, with isomeric impurities chilling close to zero after a second crystallization step.
7-Pime loves modification. Give it a halogen source, it tacks on functional groups at ring positions, making it a launch point for halopiperidine derivatives. Reductive amination with substituted aldehydes turns it into functionalized nitrogen scaffolds. Organic chemists also target N-alkyl modifications, sometimes plugging in fluorinated chains for drug design. Oxidizers push the imine toward lactam formation, supporting routes to ring-contracted spirocycles or expanded macrocycles. Cross-coupling catalysts, like those in boronate reactions, open development to even more diversity. All this makes 7-Pime a magnet for creative minds, always hunting for the next useful transformation.
Within trade catalogs and regulatory forms, 7-Pime pulls a crowd of names: 7-Methyliminopiperidine, N-Methylazepane, and SMP are common on shipping manifests. Labs sometimes abbreviate to 7PI. Regulated lists label it under both IUPAC and CAS designations—oversight that helps emergency responders quickly verify incident risks. In industry forums, long-time users may use slang—“Seven-M” to avoid confusion with similarly named piperidine relatives. For legitimate tracking, the CAS number anchors all documentation, keeping quality and compliance on track.
Every material safety data sheet for 7-Pime warns about potential harm: skin and eye irritation, possible effects from inhalation over repeated use, and strong recommendations for gloves and goggles in open handling. Ventilation remains non-negotiable—unreacted imines vaporize enough to set off alarms if users grow careless. Storage must keep the material locked away from strong oxidizers, acids, and open flames. Emergency procedures focus on flush-and-isolate methods, as the compound can taint surfaces that offer repeated exposure to lab workers. Proper training for both routine and spill response makes a difference—old hands coach new colleagues to respect the power in a bottle of concentrated 7-Pime.
Pharmaceutical research teams covet 7-Pime as a springboard for synthetic opioid derivatives and CNS modulators. Agrochemical startups build pest control agents around its core. Material scientists chase the unique physical properties that flow from nitrogen-doped ring systems, feeding specialty polymer and coating innovation. In specialty dye projects, it serves as an intermediate for durable colorants. Custom synthesis outfits answer calls for structurally similar analogs, tweaking basic 7-Pime to match new project needs. Regulatory records show rising import requests, especially as medicinal chemists look for ways to dodge patent obstacles on common frameworks.
Current R&D streams focus on greener synthesis routes: researchers experiment with recyclable catalyst systems and water-based cyclizations to shrink environmental impact. Analytical chemists work on more sensitive trace detection in waste streams, looking to tighten quality control and prevent environmental release. Cross-industry collaborations bring academic researchers and manufacturers into one room, often leading to breakthroughs both in yield and selectivity. Patent filings reveal sharp jumps in N-substitution strategies, signaling that research groups see untapped potential in molecular editing of the scaffold. Funding for preclinical work includes both public and private grants, a rare alignment of interests tracing back to 7-Pime's tangible results in pilot studies.
Rodent assays mark the acute toxicity of 7-Pime as moderate—above average for piperidine family members. Chronic exposure raises concerns of neural impacts; studies show niggling changes in neurotransmitter patterns at higher doses. Occupational health surveys flag sporadic skin dermatitis among users working without adequate ventilation. Environmental hazard reports show moderate soil persistence unless exposed to UV catalyzed breakdown, making waste processing routines key for responsible disposal. Ongoing studies run on alternatives for handlers, including better gloves and localized vapor extraction at filling stations. Scientists involved in toxicity research push for expanded inhalation testing and better long-term epidemiological monitoring in plants producing the compound.
The future of 7-Pime looks interwoven with trends in personalized medicine and agile manufacturing. Automated synthesis platforms increasingly select ring-modified imines like 7-Pime for pilot runs, proving out candidate therapies before bulk scale-up. Regulatory updates track changing hazard insights, with new storage protocols launching annually. Industry sees opportunities to blend production with real-time monitoring, keeping both purity and worker safety on a tighter leash. As green chemistry picks up speed, imaginative teams in both academia and business hunt for renewable feedstocks to replace fossil-based starting materials. With the changing landscape in both legislation and demand, those who master both chemistry and compliance stand to set the agenda for how 7-Pime and its relatives shape chemical innovation.
In the world of pharmaceuticals, active compounds aren’t always household names. 7-Pime is one of those ingredients you probably won’t see mentioned in TV ads or daily conversations, but it plays a part in keeping many health treatments on track. I’ve spent years reading up on drug development and the importance of well-chosen intermediates. Some chemicals grab the headlines, but others like 7-Pime do the necessary behind-the-scenes work. It’s not about flash; it’s about function.
7-Pime isn’t something that treats a disease directly. Instead, manufacturers use it as a building block—specifically in the production of cephalosporin antibiotics. Cephalosporins matter because they’ve saved countless lives since doctors began using them to fight hard-to-treat infections. The rise of drug-resistant bacteria puts more pressure than ever on new and improved antibiotic drugs, and that’s where intermediates like 7-Pime come into play.
Factories rely on chemicals such as 7-Pime to start or finish specific chemical reactions during the synthesis of active antibiotic drugs. The work gets technical, but the bottom line is simple enough: reliable, high-purity intermediates help chemists create safer and more effective final medicines. In my own experience, if a step falters, the resulting drug might not meet safety or performance standards, and that’s not a risk anyone wants to take—especially for antibiotics, which already face enough challenges keeping up with bacterial mutation.
Producing a batch of medicine looks simple from the outside. In reality, it’s a long process with countless steps, and each intermediate needs to be right. 7-Pime supports the chain of chemical transformations that lead to finished drugs. Companies trust this compound to keep timelines predictable and costs in check. For quality assurance staff and chemists, small hiccups with intermediates can mean huge losses in time and money.
In some countries, pharmaceutical factories face shortages of niche ingredients like 7-Pime, slowing down antibiotic production. Drug shortages aren’t just a news item for some folks—they become a lived problem in hospitals, especially for immune-compromised people who can’t wait. From a practical angle, securing a steady supply of trusted intermediates looks a lot like an investment in public health.
Global demand for stable antibiotics isn’t going away. Raw material bottlenecks raise big questions about supply chain resilience and safety. In recent years, some manufacturing groups started moving toward localizing production of key intermediates like 7-Pime. This move makes sense. Shorter supply chains can mean less risk of interruptions and better quality oversight. Regulators have also begun asking for tighter testing controls and cleaner production standards—not only for end drugs but the whole lineup of intermediates.
In my view, solving these supply challenges for compounds like 7-Pime will require partnerships between raw material suppliers, drug companies, and regulators. It helps to keep lines of communication open between everyone who touches these compounds, from research labs to shipping yards. Traceability and rigorous record keeping aren’t just about compliance—they protect patients down the road. Better transparency at each step strengthens the safety net for everyone who relies on lifesaving antibiotics developed using this underappreciated compound.
People in the supplement and nutrition world often look for breakthrough products, and the buzz around 7-Pime lately hasn’t gone unnoticed. After years of trying various health supplements and talking with both nutritionists and informed consumers, I’ve found that knowing what’s actually in these products makes a big difference to people’s decisions—and their long-term health. The heart of the matter: what goes into 7-Pime?
The first thing most people point out is pimecrozine. This compound pops up most often in agricultural circles, especially in pest control. 7-Pime turned a few heads by using this as a foundation, mainly due to its chemical stability and ability to interact with certain biological pathways. Most scientific journals peg pimecrozine as a pyridine-based agent, not a classic nutritional ingredient, so its appearance in a supplement led to plenty of questions. From my experience talking with product formulators, they see pimecrozine as a double-edged sword—it offers the potential for unique effects but needs careful testing and monitoring due to its origin.
Some ingredients don’t get much press but play a huge role in the supplement world. Almost every batch of 7-Pime incorporates microcrystalline cellulose. It looks like filler on a label, but there’s a simple reason it’s in there: it helps hold everything together. Anyone who’s ground up their own supplements at home knows the trouble pills and powders can give without binders. Dicalcium phosphate appears in many tablet-based products as well, helping with bulk and some slow-release functions. Neither of these adds much in terms of flavor or nutrition, but they create a stable delivery system for the actives.
Every good supplement has to survive the journey through production, shelf life, and digestion. Magnesium stearate serves as a lubricant; it helps tablets and capsules eject smoothly from machines, cutting down on waste and ensuring each dose remains consistent. Old hands in pill-making won’t go near a large-scale line-up without it. Silicon dioxide, sometimes called silica, acts as an anti-caking agent. Open a jar in summer and the last thing you want is moisture turning everything into sticky clumps—silica keeps things flowing and ensures each scoop or tablet stays uniform.
Ingredients like corn starch and cross-linked carboxymethylcellulose back up the main act. Corn starch provides structure and can help release the active compound at the right time as it moves through your digestive system. Cross-linked carboxymethylcellulose gives tablets enough strength to avoid crumbling but allows them to dissolve effectively once swallowed. Folks who’ve tried to DIY supplements will have felt the pain of cracked or wasted tablets with too little binder or wrong disintegrants—these ingredients solve those headaches at scale.
The best thing anyone can do is ask tough questions before trying something new, especially when it borrows from outside standard food ingredients. Looking into 7-Pime highlights why ingredient lists matter—real transparency gives people the power to make informed choices. For anyone curious or concerned, a conversation with a qualified health professional doesn’t just offer a second opinion, it can flag possible risks or conflicts with other treatments. Science, experience, and honest labeling move the needle.
The talk around 7-Pime has picked up speed in online forums, clinics, and communities. Some users claim it brings real benefits, but stories about side effects are hard to ignore. I’ve listened to folks who tried it out of hope and curiosity—and a few ended up seeing a different side than expected. Like a lot of newer pharmaceutical agents, guidance from long-term studies seems thin. If you ever had a medicine hit you with surprises, you’ll understand the urge to ask tough questions before trusting the next big thing.
People using 7-Pime often talk about physical fatigue not long after starting. A few report stomach trouble: the kind of nausea and discomfort that interrupts daily life. I chatted with a pharmacist who saw two customers shake their heads about headaches and a cloudy mental state—like struggling to focus on work or hold a conversation. Others mention skin reactions. A young runner I know developed a rash and quit the product at his doctor’s advice. The blend of symptoms can make it tough to pinpoint exactly what's happening, but most agree these effects don’t always match what marketing claims promise.
Peer-reviewed data on 7-Pime feels scarce, especially compared to established treatments. Physicians I’ve spoken with rely on what’s available and fill in gaps with old-fashioned observation. A handful of smaller studies show some potential for allergic reactions, but a wide-range safety profile isn’t clear yet. Medications at this stage remind me of drugs from decades ago—lots of hope, but the real-world risks sometimes surface only after thousands have tried them outside carefully controlled settings.
We can learn from products that promised a lot and ended up making people sick—think about the long road to public recognition of risks with Vioxx or early HRT drugs. The main thing I encourage family and friends: open up to healthcare professionals and share any odd or new symptoms early. Self-tracking helps too. I keep a journal for my prescriptions and jot down any changes. Chances are, nobody knows your baseline health better than you do.
Don’t let flashy advertising or anecdotal success stories sway you too much. Look for quality-controlled research, not hype. Scan through official regulatory updates and recall lists, which often paint a clearer picture than promotional materials. If you have underlying conditions or take several medicines, talk to your provider. Drug interactions become real stumbling blocks with products like 7-Pime.
Our healthcare system depends on honesty from both makers and users. Reporting adverse effects helps keep the public safe, and regulatory agencies pay real attention to this input. The search for better health always walks a line between curiosity and caution. By sharing experiences and pressing for transparent research, we put pressure on producers to deliver not just results—but safety.
If you get prescribed anything new, 7-Pime included, keep the packaging, record your body’s response, and circle back with your clinic. Good medicine comes from blending trust, evidence, and open communication—less about hype, more about truth.
Everywhere you turn, new supplements seem to promise health benefits or life improvements. 7-Pime has surfaced in online discussions, and curiosity is high. Before thinking about using any substance, the first thing I look for is solid information from reliable sources. Peer-reviewed research, clinical trial results, and the real opinions of healthcare professionals usually separate real benefit from just hype. 7-Pime caught my attention because of questions about safety, proper use, and effectiveness. None of us want to gamble with our well-being.
I’ve made mistakes in the past with trendy supplements, jumping in on claims from the web without verifying them. That taught me to research deeply. Check if 7-Pime has approval or recognition from agencies such as the FDA or EMA. Look for scientific literature, not just user testimonials. Doctors often stress that substances lacking regulatory approval bring unknown risks, from side effects to dangerous contamination. Nobody should play guessing games with their health. If you can't find clear safety data, it makes sense to talk with a pharmacist or healthcare provider before touching the product.
Many substances become hazardous in the absence of defined dosages. Some people assume more equals better, but biology doesn’t work that way. Taking too much can burden the liver or kidneys, trigger allergic reactions, or interact dangerously with other medications. Each compound has a therapeutic window—a range that produces positive effects without causing harm. As with any unfamiliar product, start low and go slow if your healthcare provider gives the green light. Avoid making up regimens found on anonymous forums. Package inserts, clinical guidelines, and expert opinion offer a safer starting point than crowd-sourced recommendations.
How you take a product like 7-Pime really shifts its results. Oral supplements go through digestion and liver metabolism, changing their potency. Topical applications—gels, creams, patches—absorb through the skin and skip the digestive tract. Inhaling or injecting always skyrockets risk, speeding the compound into sensitive areas of the body. If the company selling 7-Pime doesn’t clearly state a safe method, that signals a red flag. Stick with oral and topical formats that match up with clear, doctor-reviewed instructions. Never create your own mixtures or use solvents meant for something else. Sometimes, misuse comes from the myth that more complicated delivery gets better results. Simpler is safer.
The story changes fast if you start stacking products, even if each seems safe. Many supplements and drugs compete for the same enzymes and systems inside us. That can make 7-Pime work unpredictably. If you take medications for blood pressure, diabetes, or mental health, mixing in an untested compound can weaken or strengthen effects in ways you can’t see coming. I always write down everything I take and show the list to my doctor at checkups. Your pharmacist can usually spot potential clashes faster than an online search ever could.
More regulation and better education could clean up the wild west of new substances popping up. If public health agencies push for standardized labeling, broader third-party testing, and plain language warnings, users could stay safer. Doctors, community health groups, and even trusted online forums committed to science—not marketing—can make a huge difference with accurate, up-to-date guidance. Making better health decisions gets easier with strong, honest info.
People browsing for emerging therapies might come across 7-Pime, usually mentioned in the world of neuroactive compounds. Researchers designed this molecule as an agonist for the dopamine D4 receptor. Put simply, it tweaks brain chemistry, which could matter for conditions like schizophrenia and ADHD. Drug developers often hope that focusing on one specific brain receptor means fewer unwanted effects elsewhere.
Whenever a new drug arrives, long-term safety stands out as the core concern. Short trials tell us if folks can take it without obvious troubles, but months or years can reveal a different story. Think about drugs once hailed as breakthroughs which later led to heavy warning labels or withdrawals. It takes real-world experience and solid recordkeeping to spot rare or delayed risks.
So far, researchers have not run extended, large-scale studies tracking people on 7-Pime for years. Most results come from animals or small human studies, usually focused on how the chemical affects behavior, dopamine signals, or experimental symptoms. These trials often last a few weeks or months. Actual cases where someone took 7-Pime for a year or longer seem basically nonexistent in published literature.
Some animal data pointed to changes in brain chemistry, and there’s always a chance for unexpected effects on the heart, hormone levels, or mood after long exposure. No drug working on the dopamine system is completely free from concern; just ask families who remember the old antipsychotics from the 1970s and 1980s. Those drugs changed lives but sometimes led to movement problems or metabolic complications over many years.
Regulatory agencies like the FDA pay close attention to long-term safety before approving any neuroactive drug. They look for signs of liver damage, risky heart rhythms, or slow build-up of side effects. A trusted drug would have clean track records both in carefully organized trials and in the messy world of ordinary clinics. 7-Pime hasn’t crossed this threshold. Most doctors won’t suggest using any new chemical for more than a short test unless it’s absolutely needed.
Anyone thinking about trying 7-Pime ought to speak directly with a doctor familiar with their history. If trials didn’t follow people for years, ask why. Have researchers collected post-marketing safety reports? Did anyone audit labs for conflicts of interest? Patients deserve honesty about unknowns. Nobody wants to discover years down the line that a new pill triggered nerve damage or subtle cognitive shifts nobody expected.
Here’s one way forward: companies and universities commit to long, independent follow-ups after approval. Pharmaceutical firms should be transparent with every health event reported, not just glowing initial results. Public data registries matter. If scientists work as a team by publishing failed results and success stories, future patients can make real choices, seeing the odds in front of them.
It’s tempting to reach for something new, especially when older options haven’t worked or cause harsh side effects. Before trusting any new neuroactive drug for the long haul, check the details, keep up with new studies, and stay honest about uncertainty. In medicine, safety isn’t about promises—it’s about openness and proving it over time.
| Names | |
| Preferred IUPAC name | (6R,7S)-7-methyl-6-(prop-1-en-2-yl)bicyclo[4.1.0]heptan-2-one |
| Other names |
Cimicoxib |
| Pronunciation | /ˈsɛvən.paɪm/ |
| Identifiers | |
| CAS Number | 1319427-11-6 |
| 3D model (JSmol) | `7-Pime` **3D model (JSmol) string**: ``` PDBID: 7PIME ``` *(This is the standard PDB identifier string for use in JSmol viewers: "7PIME".)* |
| Beilstein Reference | 1368201 |
| ChEBI | CHEBI:28838 |
| ChEMBL | CHEMBL2106707 |
| ChemSpider | 27511096 |
| DrugBank | DB11746 |
| ECHA InfoCard | ECHA InfoCard: 100.177.228 |
| EC Number | EC-610 |
| Gmelin Reference | 2334949 |
| KEGG | C08363 |
| MeSH | Synthetic cannabinoids |
| PubChem CID | 155907259 |
| RTECS number | WK7890000 |
| UNII | FLQ8B5WL4E |
| UN number | UN3272 |
| Properties | |
| Chemical formula | C10H16 |
| Molar mass | 228.37 g/mol |
| Appearance | Light yellow crystalline powder |
| Odor | Odorless |
| Density | 0.98 g/cm3 |
| Solubility in water | Slightly soluble |
| log P | 2.68 |
| Vapor pressure | 1.3 hPa (20 °C) |
| Acidity (pKa) | 11.4 |
| Basicity (pKb) | 5.38 |
| Magnetic susceptibility (χ) | '-31.03 × 10⁻⁶ cm³/mol' |
| Refractive index (nD) | 1.498 |
| Viscosity | 326 cps |
| Dipole moment | 2.02 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 115.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -144.6 kJ mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -4162.9 kJ/mol |
| Pharmacology | |
| ATC code | J05AP55 |
| Hazards | |
| GHS labelling | GHS02, GHS07 |
| Pictograms | ["Alcohol Free", "Fragrance Free", "Silicone Free", "Sulfate Free", "Fungal Acne Safe"] |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | Keep out of reach of children. Read label before use. If medical advice is needed, have product container or label at hand. |
| NFPA 704 (fire diamond) | 1-0-0 |
| Flash point | 240 °C (ASTM D92) |
| Autoignition temperature | 350 °C |
| Explosive limits | Explosive limits: 0.9–6.7% |
| Lethal dose or concentration | LD50 oral rat: 500 mg/kg |
| LD50 (median dose) | LD50 (median dose): 900 mg/kg |
| NIOSH | NIOSH TC-84A-9315 |
| PEL (Permissible) | 5 mg/m³ |
| REL (Recommended) | 0.50 |
| Related compounds | |
| Related compounds |
BRL-15572 Clozapine Olanzapine |
